• NEBANNER

Manufacturing Companies for Condensate Treatment - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN

Manufacturing Companies for Condensate Treatment - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We enjoy an extremely good status among our prospects for our great merchandise top quality, competitive price and the ideal service for Lurasidone Hydrochloride, Ethylene Glycol Dimethacrylate, Ion Resin Exchange Water Treatment, We have a professional team for international trade. We can solve the problem you meet. We can provide the products you want. Please feel free to contact us.
Manufacturing Companies for Condensate Treatment - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN Detail:

It works by stimulating central presynaptic alpha 2- receptors. Its hypotensive effect is similar to that of nifedipine, a calcium antagonist, and captopril, an ACE inhibitor. For essential hypertension.

This product should adopt the principle of individualized medication. Generally start from the lowest dose, that is, 0.2mg, once a day, taken in the morning. Dosage adjustments should be made at three-week intervals until satisfactory results are obtained. The usual dose is 0.2mg once, twice a day (morning and evening). The maximum dose per time shall not exceed 0.4mg, and the maximum daily dose shall not exceed 0.6mg. For patients with mild or moderate renal insufficiency, the single dose should not exceed 0.2 mg or the daily dose should not exceed 0.4 mg.

This product is an α2-receptor agonist, which is an imidazoline antihypertensive drug. Used for moderate and severe primary and secondary hypertension.

Because it inhibits the secretion and movement of the gastrointestinal tract, it is also suitable for hypertensive patients suffering from ulcer disease. The combination of this medicine and diuretics can significantly improve the efficacy. It is a powerful central antihypertensive drug and a second-line antihypertensive drug. It is mainly administered locally in ophthalmology. This product has the effect of reducing intraocular pressure, and does not affect the pupil and eye adjustment mechanism. It can constrict blood vessels in the eye, reduce the production of aqueous humor, and achieve the effect of reducing intraocular pressure. It starts to take effect 15 minutes after the eye drops and can maintain the effect for about 8 hours.

Standard:EP10
Assay content:97.5-102.0%

Exterior: White or almost while powder
Package: 1kg/bag or as required by customers


Product detail pictures:

Manufacturing Companies for Condensate Treatment - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN detail pictures


Related Product Guide:

We provide fantastic energy in top quality and advancement,merchandising,gross sales and marketing and operation for Manufacturing Companies for Condensate Treatment - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN , The product will supply to all over the world, such as: Gabon, Uzbekistan, Romania, We warmly welcome you to come to visit us personally. We hope to establish a long-term friendship based on equality and mutual benefit. If you want to get in touch with us, please do not hesitate to call. We will be your best choice.
  • The customer service reprersentative explained very detailed, service attitude is very good, reply is very timely and comprehensive, a happy communication! We hope to have a opportunity to cooperate.
    5 Stars By Sara from Oman - 2017.09.30 16:36
    This company can be well to meet our needs on product quantity and delivery time, so we always choose them when we have procurement requirements.
    5 Stars By Carey from El Salvador - 2018.12.10 19:03
    Write your message here and send it to us